Co-Diagnostics, Inc. Common Stock (CODX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.72M
Last updated: Nov 17, 2026 at 11:03 AM ET
Co-Diagnostics, Inc. Common Stock (CODX) Valuation Multiples
Co-Diagnostics, Inc. Common Stock (CODX) trades at 1.6x sales and 0.1x book value. Its P/S of 1.6x is below its 5-year median of 3.8x. Its forward P/E is 15.4x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 15.4x |
| Price to sales | 1.6x |
| Price to book | 0.1x |
| PEG | N/A |
| FCF yield | -1927.4% |
Historical Medians
Against its 10-year medians, its P/B is 90.9% below 1.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.6x | 3.8x | N/A |
| P/B | 0.1x | 0.4x | 1.1x |
Valuation History
Over the 3 of the 9 year ends shown that have a P/E, its P/E ranged from 9.1x in 2021 to 45.3x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.06 | N/A | 10.0x | 0.3x |
| 2024 | $22.52 | N/A | 5.8x | 0.5x |
| 2023 | $39.94 | N/A | 5.9x | 0.5x |
| 2022 | $75.68 | 45.3x | 2.4x | 0.7x |
| 2021 | $268.17 | 9.1x | 2.7x | 2.0x |
| 2020 | $279.28 | 10.1x | 3.5x | 3.9x |
| 2019 | $26.88 | N/A | 81.6x | 11.8x |
| 2018 | $44.74 | N/A | N/A | N/A |
| 2017 | $79.28 | N/A | N/A | 179.5x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CODX
What is CODX's forward P/E ratio?
Co-Diagnostics, Inc. Common Stock has a forward P/E ratio of 15.4x.
Is CODX stock overvalued?
GNG's valuation label for CODX is Undervalued.
What is CODX's price to sales ratio?
Co-Diagnostics, Inc. Common Stock has a price to sales ratio of 1.6x.
CODX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors